Janney Montgomery Scott maintains Neutral on Acorda Therapeutics, Inc. (NASDAQ: ACOR) price target of $20.00.The analyst comments "Federal Circuit Court ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE